Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy

<b> </b>In the last decades, the use of nanocarriers for immunotherapeutic purposes has gained a lot of attention, especially in the field of tumor therapy. However, most types of nanocarriers accumulate strongly in the liver after systemic application. Due to the default tolerance-promo...

Full description

Bibliographic Details
Main Authors: Maximiliano L. Cacicedo, Carolina Medina-Montano, Leonard Kaps, Cinja Kappel, Stephan Gehring, Matthias Bros
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/9/1985